CIK: 0001728001
申报总市值
US$86.9亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AEGR 2 08-15-19 | Aegerion Pharmaceuticals | 股票-其他 | 67.68% | — | — | |
| 2 | PTCT 3 08-15-22 | Ptc Therapeutics INC | 股票-医疗保健 | 30.42% | — | -39.73% | |
| 3 | HQ8F | Apollo Endosurgery INC | 股票-其他 | 1.90% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | AEGR 2 08-15-19 | Aegerion Pharmaceuticals | +22.6% | — | 不变 |
| 2 | PTCT 3 08-15-22 | Ptc Therapeutics INC | +3.6% | -39.73% | 减仓 |
| 3 | HQ8F | Apollo Endosurgery INC | +0.9% | — | 不变 |
| 4 | ✓ | Vivus INC | — | EXIT | 清仓 |